• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种有漏洞的防御:肠道疾病中渗漏的上皮屏障

A porous defense: the leaky epithelial barrier in intestinal disease.

作者信息

Clayburgh Daniel R, Shen Le, Turner Jerrold R

机构信息

Department of Pathology, The University of Chicago, Chicago, IL 60637, USA.

出版信息

Lab Invest. 2004 Mar;84(3):282-91. doi: 10.1038/labinvest.3700050.

DOI:10.1038/labinvest.3700050
PMID:14767487
Abstract

A critical function of the intestinal mucosa is to form a barrier that separates luminal contents from the interstitium. This intestinal barrier is compromised in a number of intestinal diseases, most notably inflammatory bowel disease. In vitro studies have demonstrated that cytokines elaborated by immune cells can cause the mucosal barrier to become leaky; these cytokines are known to be increased in intestinal mucosa involved in inflammatory bowel disease. Detailed information describing the mechanisms by which altered cytokine signaling occurs is not available, but recent data implicate the cytoskeleton within epithelial cells as a critical regulator of the mucosal barrier under physiological and pathophysiological conditions. Using available data, we describe a model of intestinal disease where an initial insult to the epithelial barrier may trigger a self-amplifying cycle of immune activation, cytokine release, and further barrier dysfunction. This model is supported by the observation that pharmacological abrogation of cytokine signaling corrects both barrier defects and clinical disease in animal models and human patients, although such therapy clearly has multiple mechanisms. Other therapeutic targets that represent strategies to prevent or reverse disease processes are also considered. The overarching hypothesis is that modulation of the mucosal epithelial barrier plays a critical role in the initiation and propogation of inflammatory intestinal diseases.

摘要

肠黏膜的一项关键功能是形成一道将肠腔内容物与间质分隔开来的屏障。在许多肠道疾病中,尤其是炎症性肠病,这道肠道屏障会受到损害。体外研究表明,免疫细胞分泌的细胞因子可导致黏膜屏障渗漏;已知这些细胞因子在参与炎症性肠病的肠黏膜中会增加。目前尚无关于细胞因子信号传导改变发生机制的详细信息,但最近的数据表明,上皮细胞内的细胞骨架在生理和病理生理条件下是黏膜屏障的关键调节因子。利用现有数据,我们描述了一种肠道疾病模型,其中上皮屏障的初始损伤可能引发免疫激活、细胞因子释放和进一步屏障功能障碍的自我放大循环。这一模型得到了以下观察结果的支持:在动物模型和人类患者中,细胞因子信号传导的药理学消除可纠正屏障缺陷和临床疾病,尽管这种治疗显然有多种机制。还考虑了代表预防或逆转疾病进程策略的其他治疗靶点。总的假设是,黏膜上皮屏障的调节在炎症性肠病的发生和发展中起关键作用。

相似文献

1
A porous defense: the leaky epithelial barrier in intestinal disease.一种有漏洞的防御:肠道疾病中渗漏的上皮屏障
Lab Invest. 2004 Mar;84(3):282-91. doi: 10.1038/labinvest.3700050.
2
Inflammatory bowel disease and the apical junctional complex.炎症性肠病与顶端连接复合体
Ann N Y Acad Sci. 2006 Aug;1072:242-52. doi: 10.1196/annals.1326.017.
3
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
4
The intestinal epithelial barrier: a therapeutic target?肠上皮屏障:一个治疗靶点?
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21. doi: 10.1038/nrgastro.2016.169. Epub 2016 Nov 16.
5
Mechanisms and functional implications of intestinal barrier defects.肠道屏障缺陷的机制和功能意义。
Dig Dis. 2009;27(4):443-9. doi: 10.1159/000233282. Epub 2009 Nov 4.
6
Intestinal permeability defects: is it time to treat?肠通透性缺陷:是否到了治疗的时机?
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1075-83. doi: 10.1016/j.cgh.2013.07.001. Epub 2013 Jul 12.
7
Role of the intestinal barrier in inflammatory bowel disease.肠道屏障在炎症性肠病中的作用。
World J Gastroenterol. 2008 Jan 21;14(3):401-7. doi: 10.3748/wjg.14.401.
8
Mechanism of cytokine modulation of epithelial tight junction barrier.细胞因子调节上皮紧密连接屏障的机制。
Front Biosci (Landmark Ed). 2009 Jan 1;14(7):2765-78. doi: 10.2741/3413.
9
The tight junction in inflammatory disease: communication breakdown.在炎症性疾病中紧密连接:通讯中断。
Curr Opin Pharmacol. 2009 Dec;9(6):715-20. doi: 10.1016/j.coph.2009.06.022. Epub 2009 Jul 24.
10
The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.托法替尼(一种 JAK 抑制剂)可挽救细胞因子诱导的肠上皮细胞和类器官的屏障功能障碍。
Inflamm Bowel Dis. 2020 Feb 11;26(3):407-422. doi: 10.1093/ibd/izz266.

引用本文的文献

1
Extract Ameliorates Colitis in In Vitro and In Vivo Models Through Modulation of mTOR Axis and Gut Microbiota Composition.提取物通过调节mTOR轴和肠道微生物群组成改善体外和体内模型中的结肠炎。
Foods. 2025 Feb 20;14(5):714. doi: 10.3390/foods14050714.
2
Dual action tofacitinib-loaded PLGA nanoparticles alleviate colitis in an IBD mouse model.载有双重作用托法替布的聚乳酸-羟基乙酸共聚物纳米颗粒可缓解炎症性肠病小鼠模型中的结肠炎。
Drug Deliv Transl Res. 2024 Nov 11. doi: 10.1007/s13346-024-01736-1.
3
Microbial Extracellular Vesicles in Host-Microbiota Interactions.
微生物细胞外囊泡在宿主-微生物群相互作用中的作用。
Results Probl Cell Differ. 2024;73:475-520. doi: 10.1007/978-3-031-62036-2_19.
4
Junctions at the crossroads: the impact of mechanical cues on endothelial cell-cell junction conformations and vascular permeability.交叉口的连接点:机械线索对内皮细胞-细胞连接构象和血管通透性的影响。
Am J Physiol Cell Physiol. 2024 Oct 1;327(4):C1073-C1086. doi: 10.1152/ajpcell.00605.2023. Epub 2024 Aug 12.
5
Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis.二十二碳六烯酸(DHA)可减轻实验性结肠炎引起的炎症和损伤。
Eur J Nutr. 2024 Oct;63(7):2801-2813. doi: 10.1007/s00394-024-03468-x. Epub 2024 Aug 6.
6
Parenteral Nutrition, Inflammatory Bowel Disease, and Gut Barrier: An Intricate Plot.肠外营养、炎症性肠病和肠道屏障:一个错综复杂的情节。
Nutrients. 2024 Jul 17;16(14):2288. doi: 10.3390/nu16142288.
7
Leaky gut and inflammatory biomarkers in a medication overuse headache model in male rats.肠道渗漏和炎症生物标志物在雄性大鼠药物过度使用性头痛模型中的作用。
Turk J Med Sci. 2023 Oct 25;54(1):33-41. doi: 10.55730/1300-0144.5763. eCollection 2024.
8
Mind over Microplastics: Exploring Microplastic-Induced Gut Disruption and Gut-Brain-Axis Consequences.意识战胜微塑料:探索微塑料引起的肠道紊乱及肠-脑轴后果
Curr Issues Mol Biol. 2024 Apr 30;46(5):4186-4202. doi: 10.3390/cimb46050256.
9
Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn's Disease-associated Perianal Fistulas from Cryptoglandular Fistulas.活化的 HLA-DR+CD38+效应性 Th1/17 细胞可区分克罗恩病相关肛周瘘管和隐匿性肛腺瘘管。
Inflamm Bowel Dis. 2024 Nov 4;30(11):2146-2161. doi: 10.1093/ibd/izae103.
10
Pretreatment with an antibiotics cocktail enhances the protective effect of probiotics by regulating SCFA metabolism and Th1/Th2/Th17 cell immune responses.抗生素鸡尾酒预处理通过调节 SCFA 代谢和 Th1/Th2/Th17 细胞免疫应答增强益生菌的保护作用。
BMC Microbiol. 2024 Mar 18;24(1):91. doi: 10.1186/s12866-024-03251-2.